Xi Chen

13.4k total citations · 2 hit papers
347 papers, 8.1k citations indexed

About

Xi Chen is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Xi Chen has authored 347 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Molecular Biology, 70 papers in Epidemiology and 65 papers in Oncology. Recurrent topics in Xi Chen's work include Autophagy in Disease and Therapy (39 papers), Cancer-related molecular mechanisms research (21 papers) and RNA modifications and cancer (20 papers). Xi Chen is often cited by papers focused on Autophagy in Disease and Therapy (39 papers), Cancer-related molecular mechanisms research (21 papers) and RNA modifications and cancer (20 papers). Xi Chen collaborates with scholars based in China, United States and Japan. Xi Chen's co-authors include Jack L. Strominger, Xiao-Ming Yin, Konrad Krzewski, Xiangfeng Cong, Hao Zhang, Chih‐Wen Lin, Xiwen Xiong, Min Li, Xiaoyun Chen and X. Charlie Dong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Xi Chen

324 papers receiving 8.0k citations

Hit Papers

Epigenetically upregulated oncoprotein PLCE1 drives esoph... 2019 2026 2021 2023 2019 2025 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Chen China 45 3.7k 1.6k 1.4k 1.4k 1.4k 347 8.1k
Shu Zhang China 47 4.6k 1.2× 1.3k 0.8× 1.9k 1.3× 1.8k 1.3× 1.2k 0.9× 351 9.6k
Jian Liu China 43 3.4k 0.9× 1.4k 0.9× 1.3k 0.9× 1.5k 1.1× 675 0.5× 307 6.9k
Yang Sun China 53 4.8k 1.3× 2.3k 1.5× 1.5k 1.1× 822 0.6× 952 0.7× 299 9.4k
Mohammad Hashemi Iran 40 3.7k 1.0× 1.2k 0.8× 782 0.5× 1.4k 1.0× 1.5k 1.1× 350 7.6k
Xiangdong Wang China 47 3.3k 0.9× 1.3k 0.8× 1.1k 0.8× 992 0.7× 1.0k 0.7× 246 7.6k
Ling Li China 45 3.7k 1.0× 1.0k 0.7× 1.1k 0.8× 1.1k 0.8× 951 0.7× 304 7.0k
Jin Zhang China 42 4.7k 1.3× 1.4k 0.9× 1.5k 1.0× 1.5k 1.1× 629 0.5× 232 8.5k
Martin Bilban Austria 49 4.8k 1.3× 2.1k 1.3× 966 0.7× 973 0.7× 839 0.6× 143 8.4k
Elsa Sánchez‐López Spain 38 4.1k 1.1× 2.2k 1.4× 979 0.7× 793 0.6× 1.1k 0.8× 53 7.7k
Takashi Kojima Japan 50 4.1k 1.1× 889 0.6× 1.0k 0.7× 1.0k 0.7× 751 0.6× 235 8.8k

Countries citing papers authored by Xi Chen

Since Specialization
Citations

This map shows the geographic impact of Xi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Chen more than expected).

Fields of papers citing papers by Xi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Chen. The network helps show where Xi Chen may publish in the future.

Co-authorship network of co-authors of Xi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Chen. A scholar is included among the top collaborators of Xi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Chen. Xi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoyu, et al.. (2025). Advances in Immunotherapy for HER2 Low-Expressing Triple-Negative Breast Cancer. Cancer Management and Research. Volume 17. 2985–2995.
2.
3.
Tang, Kai, Xi Chen, Ying Xin, et al.. (2025). Intercellular contractile force attenuates chemosensitivity through Notch-MVP-mediated nuclear drug export. Proceedings of the National Academy of Sciences. 122(19). e2417626122–e2417626122. 1 indexed citations
4.
Zheng, Qi, Xun Song, Ying Zhang, et al.. (2024). Qinzhuliangxue mixture ameliorates psoriasis by restraining apoptosis in psoriasis via downregulating the MDA-5 pathway. Journal of Ethnopharmacology. 328. 118059–118059. 3 indexed citations
5.
Li, Junyan, et al.. (2024). Galangin alleviated Doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through GSTP1/JNK pathway. Phytomedicine. 134. 155989–155989. 16 indexed citations
6.
Chen, Wei, et al.. (2024). Inductive Link Prediction for Sequential-emerging Knowledge Graph. abs/1605.06523. 5753–5766.
7.
Zhang, Huimin, Lin Su, Mingxi Liu, et al.. (2023). Targeting upregulation of the immunosuppressive activity of MDSCs with indirubin as a novel strategy to alleviate psoriasis. International Immunopharmacology. 123. 110710–110710. 2 indexed citations
8.
Chen, Xi, Zhizhen Wang, Peng Zheng, et al.. (2023). Impaired mitophagosome–lysosome fusion mediates olanzapine‐induced aging. Aging Cell. 22(11). e14003–e14003. 8 indexed citations
9.
Zhao, Mengxue, et al.. (2023). 1,25(OH)2D3 alleviates oxidative stress and inflammation through up-regulating HMGCS2 in DSS-induced colitis. International Immunopharmacology. 125(Pt A). 111131–111131. 4 indexed citations
10.
Tang, Long, Xi Chen, Xiangming Kong, et al.. (2023). Anti-aging effect of methylurolithin A and its amide derivatives on nematode Caenorhabditis elegans. Tetrahedron Letters. 118. 154389–154389. 3 indexed citations
11.
Chen, Xi, et al.. (2023). Unmasking the Hypoxia Landscape in Cervical Cancer: S100A2 and Its Implication for Immunotherapy Resistance. Reproductive Sciences. 31(1). 96–98. 1 indexed citations
12.
Chen, Xi, et al.. (2022). Seromucinous and Mucinous Borderline Ovarian Tumors: We Need to Know More. Reproductive Sciences. 30(5). 1684–1685. 4 indexed citations
13.
Chen, Xi & Kewei Ma. (2021). Neoadjuvant Therapy in Lung Cancer: What Is Most Important: Objective Response Rate or Major Pathological Response?. Current Oncology. 28(5). 4129–4138. 12 indexed citations
14.
Liu, Liu, Xiaoying Sun, Yi Lü, et al.. (2020). Fire Needle Therapy for the Treatment of Psoriasis: A Quantitative Evidence Synthesis. The Journal of Alternative and Complementary Medicine. 27(1). 24–37. 13 indexed citations
15.
Short, Sarah P., Joshua J. Thompson, Anthony J. Bilotta, et al.. (2019). Serine Threonine Kinase 17A Maintains the Epithelial State in Colorectal Cancer Cells. Molecular Cancer Research. 17(4). 882–894. 13 indexed citations
17.
Naik, Meghna U., Pravin Patel, Xi Chen, et al.. (2016). Ask1 regulates murine platelet granule secretion, thromboxane A2 generation, and thrombus formation. Blood. 129(9). 1197–1209. 51 indexed citations
18.
Cho, Hyun Jin, Jia Yu, Chengsong Xie, et al.. (2014). Leucine‐rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER –Golgi export. The EMBO Journal. 33(20). 2314–2331. 61 indexed citations
19.
Xia, Mi‐Zhen, Hua Wang, Xi Chen, et al.. (2012). Melatonin modulates TLR4‐mediated inflammatory genes through MyD88‐ and TRIF‐dependent signaling pathways in lipopolysaccharide‐stimulated RAW264.7 cells. Journal of Pineal Research. 53(4). 325–334. 150 indexed citations
20.
Krzewski, Konrad, Xi Chen, & Jack L. Strominger. (2008). WIP is essential for lytic granule polarization and NK cell cytotoxicity. Proceedings of the National Academy of Sciences. 105(7). 2568–2573. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026